Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Scolioscan
AddedFeb 17, 2024
UpdatedJun 18, 2026
Scolioscan

Scolioscan

Seed

Scolioscan: Pioneering in R&D, production, and distribution of medical imaging technology.

HQ
Victoria, Central and Western District, HK
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Founded in Hong Kong, Scolioscan specializes in the research, development, production, and distribution of advanced medical imaging technology. The company's core mission is to revolutionize scoliosis diagnosis and monitoring through non-invasive, radiation-free ultrasound systems. Scolioscan's flagship product, the Scolioscan Ultrasound System, offers a safer alternative to traditional X-ray methods, targeting healthcare providers and patients seeking reliable and frequent scoliosis assessments.

Notable individuals affiliated with Scolioscan include experts in medical imaging and healthcare technology. The company has garnered significant attention for its innovative approach, receiving accolades within the medical community. Scolioscan's impact is evident in its contribution to safer scoliosis management, reducing radiation exposure for patients globally.

Scolioscan - Similar Companies

Sonosite logo

Sonosite

sonosite.com

Corscans logo

Corscans

Smart Scan Medical Imaging logo

Smart Scan Medical Imaging

myssmi.com

Physiosonics logo

Physiosonics

Verdure Imaging logo

Verdure Imaging

verdureimaging.com

Exo logo

Exo

exo.inc

Kolo Medical logo

Kolo Medical

SpineOvations logo

SpineOvations

SpineForm logo

SpineForm

Real Time Imaging Technologies logo

Real Time Imaging Technologies

Saset Healthcare logo

Saset Healthcare

sasethealthcare.in

Dbmedx logo

Dbmedx

dbmedx.com

EndoSound logo

EndoSound

endosound.com

HeartScan logo

HeartScan

heartscan.com

Singular Medical Technologies logo

Singular Medical Technologies

Scolioscan - Quick Facts

Who are Scolioscan's competitors?

Companies similar to Scolioscan include Sonosite, Corscans, Smart Scan Medical Imaging and Physiosonics.

When was Scolioscan founded?

Scolioscan was founded in 2012.

Where is Scolioscan's headquarters located?

Scolioscan's headquarters is located in Victoria, Central and Western District, HK.

When was Scolioscan's last funding round?

Scolioscan's most recent funding round was for $40M (USD) in May 2023.

How much has Scolioscan raised to-date?

As of May 18, 2023, Scolioscan has raised a total of $40M (USD).

How many employees does Scolioscan have?

Scolioscan has 30 employees as of Feb 4, 2024.

Scolioscan - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Ultrasound
Geographic Exposure
  • Global
Revenue
  • Software
Main Product
  • Medical Imaging
  • Ultrasound
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified